Coplan definitely seemed to actively promote FDA approval on their ESwab product, but cannot find any such approval on PhenoMatrix.
Not at all naughty to be promoting a idea / potential product if they're not giving any representation as to regulatory approvals which seem absent on all related promotional material.
Seems LBT / CCS has first mover advantage. No wonder they are so keen to do lab testing, get distribution network and service / training platform in place.
Why the hype?, page-106
Add LBT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.5¢ |
Change
-0.001(6.25%) |
Mkt cap ! $23.30M | |||
| Open | High | Low | Value | Volume |
| 1.6¢ | 1.6¢ | 1.5¢ | $8.549K | 565.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 250000 | 1.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.6¢ | 188838 | 1 |
View Market Depth
| Last trade - 11.33am 09/07/2024 (20 minute delay) ? |
| LBT (ASX) Chart |